European Pharmaceutical Review

JANUARY 25, 2024

These standardised documents provide meticulously curated and scientifically approved information. Article 63 EMA (29 January 2020). Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. 11 This requirement directly contradicts what is included in Article 63.

Packaging 98

Packaging Documentation Pharmaceutical Companies Pharmaceutical Companies 98

Pharmaceutical Technology

APRIL 14, 2023

Although the organisation previously shared a draft version of the report in February, the revised document features new details on the drugs’ potential fair pricing. Obeticholic acid will be in the spotlight when an approval package for its use in NASH will be discussed at a Gastrointestinal Drugs Advisory Committee meeting on May 19.

Packaging 52

Packaging Documentation 52

ISPE

MAY 11, 2023

The key to data integrity compliance is a well-functioning data governance system 1 , 2 in which the data flow path for all business processes and equipment—such as in manufacturing, laboratory, and clinical studies—is fully understood and documented by a detailed process data flow map. Many organizations already have documented process maps.

Packaging 52

Packaging Documentation Communication Data Entry 52

ISPE

MARCH 7, 2023

As such there’s a growing question of how the industry will improve the sustainability profile of its existing medicines and ensure that sustainability is designed into new medicines, such as products, with a reduced environmental risk, greener manufacturing technologies, and recyclable delivery systems and packaging. 9 December 2021.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

ISPE

MARCH 29, 2023

Concept Paper: M4Q(R2) Common Technical Document on Quality Guideline.” If elements such as these are adopted during the revision of ICH M4Q, this could influence global regulatory agencies to eliminate the requirement for custom Module 2 commitment documents. The authors propose using Module 2.3 Published 15 November 2021.

Documentation 52

Documentation Dosage Packaging Communication 52

ISPE

MARCH 29, 2023

Concept Paper: M4Q(R2) Common Technical Document on Quality Guideline.” If elements such as these are adopted during the revision of ICH M4Q, this could influence global regulatory agencies to eliminate the requirement for custom Module 2 commitment documents. The authors propose using Module 2.3 Published 15 November 2021.

Documentation 52

Documentation Dosage Packaging Communication 52

The FDA Law Blog

OCTOBER 5, 2022

The proposed rule is intended to align with current nutrition science, the Dietary Guidelines for Americans 2020-2025 and the 2016 nutrition labeling regulation (which also was intended to align with the Dietary Guidelines for Americans). As a result, there generally will be no incentive to fortify foods with certain beneficial nutrients.

FDA 52

FDA Labelling Packaging Documentation 52

PQA

JUNE 27, 2024

In parallel with measure development, PQA initiated a research project in 2020 to identify facilitators and barriers impacting specialty pharmacy prescription turnaround time. Pilot participants were provided a technical package containing all resources needed to accurately calculate the SP-TAT-PH measure.

Specialty Pharmacies 40

Specialty Pharmacies Communication Packaging Documentation 40

ISPE

SEPTEMBER 11, 2023

The setpoint for “proper” air velocity in cleanroom systems is documented in standards and regulations as 0.45 x, a free and open-source computational fluid dynamics (CFD) software package. link] The setpoint for “proper” air velocity in cleanroom systems is documented in standards and regulations as 0.45 m/s up to 0.54

Documentation 52

Documentation FDA Packaging Communication 52

ISPE

AUGUST 29, 2022

For changes requiring approval before implementation, once the necessary information has been submitted across regions, each health authority must review the data package and documentation based on local requirements. laboratory notebooks, batch records, and technical reports) to submission documents (e.g.,

Documentation 52

Documentation FDA Communication Packaging 52

European Pharmaceutical Review

NOVEMBER 24, 2022

Indeed, a 2020 operation coordinated by Europol across 27 countries led to the seizure of more than 25 million units of counterfeit anticancer drugs and erectile dysfunction medicines among other fake drugs worth nearly €73 million. One area in which the problem can be tackled effectively is product packaging.

Packaging 111

Packaging Labelling Documentation Dosage 111

ISPE

AUGUST 30, 2022

In this article, the term “raw material” refers to a material used in the manufacturing and packaging of a drug substance (DS) or a drug product (DP). Finally, the DP is packaged in a suitable container to ensure continued quality. The absence of any of the listed documentation should be scientifically justified.

Documentation 52

Documentation FDA Packaging Communication 52

The Checkup by Singlecare

MARCH 6, 2023

“However, since children’s dosing recommendations may vary between Benadryl products, it’s best to check the package label for dosing instructions to ensure appropriate and safe dosing,” says Dr. Johnson-Arbor. Dosing for the topical versions of Benadryl will differ, so always follow package instructions or consult your healthcare provider.

Health and Personal Care Stores 98

Health and Personal Care Stores Packaging Documentation Dosage 98

pharmaphorum

JANUARY 18, 2022

million in 2020 and with the rapid growth of the industry, is expected to grow at a CAGR of 8.95% up to 2027. Primary Packaging material designers. Secondary packagers. Understand requirements to facilitate the documentation preparation needed to obtain a NB Opinion. Who should Attend: Drug-delivery developers.

Packaging 52

Packaging FDA Documentation Vaccines 52

The Checkup by Singlecare

FEBRUARY 16, 2024

“Antioxidant” has become a hyper-common wellness buzzword, slapped on health food packages so often that many people don’t think twice about it. 10 potential health benefits of NAC Some of NAC’s uses are time-tested and well-documented, like its efficacy in treating acetaminophen overdose.

Immunization 83

Immunization Dosage Packaging FDA 83

The Thyroid Pharmacist

JULY 29, 2022

I was inspired to write this blog after the September 2020 Cameron Peak fires in Colorado. Feel free to use my own health timeline as a guideline to document your health journey. Most filter manufacturers have pictures on their filter packaging that indicate what they will and will not filter, along with the MERV rating.

Health and Personal Care Stores 52

Health and Personal Care Stores Compounding Immunization Labelling 52

pharmaphorum

FEBRUARY 2, 2022

As the COVID-19 pandemic ricocheted around the world at the start of 2020, researchers were faced with a stark choice – go remote or go home. Through a series of workshops and surveys, which collected the views of research professionals, patients and carers, the group has developed a new guidance document. A practical consensus.

Documentation 52

Documentation Packaging Communication 52

The People's Pharmacy

MAY 8, 2023

“The FDA said Global Pharma failed to use adequate, tamper-evident packaging and distributed the drugs without proper preservatives.” There have been problems with records in the past: deceit, falsification of documents and even outright fraud. Visitors to this website report a number of generic drug problems.

FDA 72

FDA Pharmaceutical Companies Pharmaceutical Companies Medical Schools 72

ISPE

SEPTEMBER 11, 2023

4 , 5 Additionally, reducing shipping limitations—such as packaging, storage, and transportation durations—helps speed up patient access in certain instances while ensuring there is no negative impact to the product’s critical quality attributes (CQAs). 3 (2020):e2970. 16 June 2020. 10 (2020):1861–75. 34 Maschan, M.,

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

ISPE

SEPTEMBER 10, 2023

In these countries, a secondary packaging site change or an active pharmaceutical ingredient (API) manufacturing site addition triggers a new submission equivalent to that required for approval of a generic drug or a line extension, whereas these site changes may be filed as a notification in the US and EU.

Documentation 98

Documentation Process Improvement Packaging Pharmaceutical Companies 98

ISPE

JULY 6, 2023

3 , 5 , 6 Historically, the highest number of FDA approvals—60% of total marketed CM drugs—occurred from 2018 to 2020 (see Table 1) and although 2021 approvals decreased to pre-2018 levels, 2022 saw two approvals: 13% of total marketed CM drugs. 12 (December 2020):2874–89. Published 18 August 2020. doi:10.1021/acs.oprd.0c00383

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Dosage Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

APRIL 8, 2025

Given that multiple work packages may often start or end together, or else take longer than others ( Figure 1 ), the introduction of new PAT requires assessment and planning by multiple departments. Any documentation, such as validation reports then helps with compliance and later regulatory submissions and requests.

Documentation 52

Documentation Packaging FDA 52